[CH:1]([N:4]1[CH2:9][CH2:8][N:7]([C:10]2C=[CH:14][C:13]([NH:16][C:17]3[C:18]4[N:19]([N:31]=[CH:32][N:33]=4)[C:20]([C:23]4[CH:28]=[CH:27][N:26]=[C:25]([CH2:29][OH:30])[CH:24]=4)=[CH:21][N:22]=3)=[CH:12][CH:11]=2)[CH2:6][CH2:5]1)([CH3:3])[CH3:2].BrC1N2N=CN=C2C(NC2C=NC(N3CCN(C(C)C)CC3)=CC=2)=[N:37]C=1>>[CH:1]([N:4]1[CH2:5][CH2:6][N:7]([C:10]2[N:37]=[CH:14][C:13]([NH:16][C:17]3[C:18]4[N:19]([N:31]=[CH:32][N:33]=4)[C:20]([C:23]4[CH:28]=[CH:27][N:26]=[C:25]([CH2:29][OH:30])[CH:24]=4)=[CH:21][N:22]=3)=[CH:12][CH:11]=2)[CH2:8][CH2:9]1)([CH3:3])[CH3:2]This compound may be prepared using the methods as described for Compound 83, using (5-bromo-[1,2,4]triazolo[1,5-a]pyrazin-8-yl)-[6-(4-isopropylpiperazin-1-yl)pyridin-3-yl]amine in Step 4. LCMS: Rt=0.71 min (95%), m/z (ESI) 446 (M+H)+.